It is a heterologous disease and categorized corresponding to the so-called intrinsic breast cancer subtypes employing the expression of estrogen receptor (ER), progesterone (PR) and human epidermal growth factor receptor 2 (HER2), together with the frequency of ki-67 (83, 84). Here, ESR1 is linked to breast carcinoma.